Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Deloitte
Citi
Cerilliant
Moodys
UBS
Chubb
McKesson
Boehringer Ingelheim

Generated: April 22, 2018

DrugPatentWatch Database Preview

TRI-LEGEST FE Drug Profile

« Back to Dashboard

Which patents cover Tri-legest Fe, and when can generic versions of Tri-legest Fe launch?

Tri-legest Fe is a drug marketed by Barr and is included in one NDA.

The generic ingredient in TRI-LEGEST FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for TRI-LEGEST FE
Drug patent expirations by year for TRI-LEGEST FE

US Patents and Regulatory Information for TRI-LEGEST FE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr TRI-LEGEST FE ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 076105-001 Oct 26, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Cipla
Deloitte
Chubb
Merck
Medtronic
Healthtrust
Federal Trade Commission
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.